ランキング
価格
はじめての方へ
ログイン
無料体験
米国企業
Cardlytics, Inc.
Raw
Cardlytics, Inc.
CDLX
時価総額
$6494.9万
PER
購入データ活用のコマースメディアプラットフォームの米国最大手。金融機関チャネルでの広告配信とPOSデータ解析プラットフォームを展開。2018年2月のIPOや2024年の上位5社が売上の16%を占める実績。米国中心に英国や欧州で展開。
マイリストに追加
マイリストに追加
概要
財務
サマリーテーブルに戻る
十億
百万
千
USD
年次
四半期
Download CSV
2018年
12月31日
2019年
12月31日
2020年
12月31日
2021年
12月31日
2022年
12月31日
2023年
12月31日
2024年
12月31日
Net Loss
-53
-17
-55
-129
-465
-135
-189
Credit loss expense
-
-
1
2
2
2
6
Depreciation and amortization
3
5
8
30
38
26
26
Capitalized Contract Cost, Amortization, Interest Expense
0
0
0
1
2
2
2
Amortization of right-of-use asset
-
-
4
6
6
3
2
Goodwill and Intangible Asset Impairment
-
-
-
-
453
71
132
Loss on divestiture
-
-
-
-
-
-7
-
Amortization of Debt Discount (Premium)
-
-
-
10
-
-
-13
Stock-based compensation expense
27
16
32
50
45
41
40
Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability
-
-
-
1
-128
1
0
Other non-cash expense (income), net
-5
-1
1
1
-7
4
-1
Income tax benefit
-
-
-
8
-1
-
-
Accounts receivable and contracts assets, net
9
26
2
28
5
8
-12
Prepaid expenses and other assets
2
2
0
1
-1
-2
-1
Accounts payable
1
-1
0
1
-1
0
0
Other accrued expenses
3
6
-1
-1
-10
-7
-7
Partner Share liability
4
14
-4
9
2
0
-16
Customer Incentive liability
4
8
4
13
1
-1
-7
Net cash used in operating activities
-19
11
-8
-39
-54
-0
-9
Acquisition of property and equipment
6
8
5
3
1
1
2
Acquisition of patents
0
0
0
0
0
-
-
Capitalized software development costs
1
3
5
9
12
12
18
Business acquisitions, net of cash acquired
-
-
-
494
2
-
-
Proceeds from Divestiture of Businesses, Net of Cash Divested
-
-
-
-
-
2
1
Net cash used in investing activities
-7
-11
-10
-507
-16
-10
-19
Proceeds from issuance of debt
-
-
-
-
-
30
173
Principal payments of debt
53
47
0
-
0
0
199
Proceeds from Derivative Instrument, Financing Activities
-
-
-
-
-
-
0
Proceeds from issuance of common stock
72
91
10
486
0
0
49
Settlement of contingent consideration
-
-
-
-
-
50
14
Repurchase of common stock
-
-
-
-
40
-
-
Equity issuance costs
2
0
-
0
0
-
0
Debt issuance costs
0
0
0
0
0
-
6
Net cash provided by (used in) financing activities
65
44
206
486
-40
-20
1
Effect of exchange rates on cash, cash equivalents and restricted cash
-0
0
0
-1
-2
0
-0
Net decrease in cash, cash equivalents and restricted cash
39
45
189
-60
-112
-30
-26
Cash paid for interest
-
-
-
-
2
4
6
Noncash Transaction, Stock Issuance
-
-
-
-
-
-
27